HanAll Biopharma and Daewoong Pharmaceutical Co-invest in Vincere Biosciences for Collaborative Opportunities in Parkinson's Disease
- Written by PR Newswire
 |
- HanAll Biopharma and Daewoong Pharmaceutical have co-invested in Vincere Biosciences.
- These mission-aligned companies are collaborating to develop small-molecule therapies for Parkinson's patients, benefiting from their combined expertise in clinical development and disease biology.
- The parties will also continue to explore opportunities to expand...
